Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution

Long-term oncologic outcomes of neoadjuvant concurrent chemoradiotherapy with capecitabine and radical surgery in locally advanced rectal cancer: 10-year experiences at a single institution

Bibliographic Details
Main Authors:	Lee, Kyung Ha, Kim, Jin Soo, Kim, Ji Yeon
Format:	Online
Language:	English
Published:	The Korean Surgical Society 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064228/

Similar Items

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
by: Lee, Sung Uk, et al.
Published: (2013)

Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
by: Wanghua Chen, et al.
Published: (2018-08-01)

Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
by: Liu, Guo-Chen, et al.
Published: (2016)

A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer
by: Lee, Kyung Ha, et al.
Published: (2013)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
by: An, Ji Yeong, et al.
Published: (2013)

Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
by: Jiraporn Setakornnukul, et al.
Published: (2018-03-01)

Comparison between preoperative and postoperative concurrent chemoradiotherapy for rectal cancer: an institutional analysis
by: Lee, Jeong Won, et al.
Published: (2013)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
by: Kim, Yeon-Joo, et al.
Published: (2013)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
by: Lee, Hong Seok, et al.
Published: (2016)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Li, Yi, et al.
Published: (2016)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
by: Tokuhara, Katsuji, et al.
Published: (2016)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Travaini, Laura L, et al.
Published: (2016)

Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study
by: Miki, Yoshitaka, et al.
Published: (2014)

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
by: Chong, Yousun, et al.
Published: (2014)

GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer
by: Lee, Hee Yeon, et al.
Published: (2015)

Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
by: Chen, Yu-Pei, et al.
Published: (2015)

Treatment outcomes of neoadjuvant concurrent chemoradiotherapy followed by esophagectomy for patients with esophageal cancer
by: Kim, Yong-Hyub, et al.
Published: (2015)

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
by: Perpar Ana, et al.
Published: (2015-06-01)

Mesenteric ischemia after capecitabine treatment in rectal cancer and resultant short bowel syndrome is not an absolute contraindication for radical oncological treatment
by: Perpar, Ana, et al.
Published: (2015)

Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis
by: Wang, Xiao-Jie, et al.
Published: (2016)

S-1-Based versus Capecitabine-Based Preoperative Chemoradiotherapy in the Treatment of Locally Advanced Rectal Cancer: A Matched-Pair Analysis
by: Su, Meng, et al.
Published: (2014)

A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinoma
by: Zhu, Ji, et al.
Published: (2013)

Oncologic impact of pathologic response on clinical outcome after preoperative chemoradiotherapy in locally advanced rectal cancer
by: Yoon, Wook Hyeon, et al.
Published: (2015)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Anvari, Kazem, et al.
Published: (2015)

Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction
by: Zhao, Qun, et al.
Published: (2015)

Neoadjuvant capecitabine, radiotherapy, and bevacizumab (CRAB) in locally advanced rectal cancer: results of an open-label phase II study
by: Velenik, Vaneja, et al.
Published: (2011)

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer
by: Kwak, Yoo-Kang, et al.
Published: (2014)

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari, Chiara, et al.
Published: (2011)

Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
by: Mihmanlı, Mehmet, et al.
Published: (2016)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
by: Meulendijks, D, et al.
Published: (2014)

Preoperative Concurrent Chemoradiotherapy for Locally Advanced Rectal Cancer: Treatment Outcomes and Analysis of Prognostic Factors
by: Kong, Moonkyoo, et al.
Published: (2012)

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer
by: Dellas, Kathrin, et al.
Published: (2013)

Laryngeal preservation in stage III/IV resectable laryngo-hypopharyngeal squamous cell carcinoma following concurrent chemoradiotherapy with capecitabine/cisplatin
by: AHN, DONGBIN, et al.
Published: (2013)

Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE)
by: Chang Woo Kim, et al.
Published: (2018-05-01)

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer
by: HASEGAWA, MASAHIRO, et al.
Published: (2014)

Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
by: Chih-Yi Chen, et al.
Published: (2018-07-01)

Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer
by: SHOJI, HISANORI, et al.
Published: (2016)

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Svoboda, Marek, et al.
Published: (2012)

Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
by: Peng, Hai-Hua, et al.
Published: (2013)